Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Exp Neurol. 2014 Mar 25;256:1–6. doi: 10.1016/j.expneurol.2014.03.005

Figure 1.

Figure 1

Oral administration of D156844 improved the survival of and delayed the onset of body mass loss in SMNΔ7 SMA mice maintained on the PicoLab20 diet. (A) Kaplan-Meier survival plot for SMNΔ7 SMA mice maintained on the PicoLab20 diet receiving either vehicle (dashed line; n=12) or 3 mg/kg/d D156844 (solid line; n=14) beginning at PND04. (B) Kaplan-Meier onset of body mass loss plot for SMNΔ7 SMA mice maintained on the PicoLab20 diet receiving either vehicle (dashed line; n=12) or 3 mg/kg/d D156844 (solid line; n=14) beginning at PND04.